The Oxford vaccine group has launched a trial to assess the efficacy of the AstraZeneca vaccine on children and young adults aged 6 to 17. Watch: According to the group, the study will assess if children can be protected from coronavirus with the new vaccine called ChAdOx1 nCoV-19.

AstraZeneca vaccine to be tested on children to test efficacy

Union Minister Prakash Javadekar on Saturday said that Indian government had approved emergency use of AstraZeneca/ Oxford University coronavirus vaccine, also known as Covishield in India. The minister said that the government had given a go-ahead on Friday.

India: AstraZeneca COVID-19 vaccine approved for emergency use

AstraZeneca has announced that its vaccine candidate has shown an average efficacy of about 70% , The vaccine candidate has been developed along with the Oxford. The potential vaccine against the novel coronavirus maybe around 90 percent effective, the company said citing interim analysis of results from late-stage clinical trials.

Oxford-AstraZeneca coronavirus vaccine shows 70% efficacy

Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects.

AstraZeneca says COVID-19 vaccine candidate is 70% effective

The Oxford University and British pharmaceutical giant AstraZeneca have announced on Monday that their vaccine for the novel coronavirus could be around 70% effective under one dosing regimen.

Oxford-AstraZeneca COVID-19 vaccine is 70% effective